COVID-19: Alzheimer’s risk factor? Yes. Alzheimer’s cause? Maybe. As research continues, the link between COVID, inflammation, and neurodegeneration becomes clearer. Memory loss, confusion, cognitive…
Certain medications and health factors could increase your risk of side effects when taking LEQEMBI™ and other monoclonal antibody drugs for Alzheimer’s. Here’s what…
Phil Gutis, a career reporter and writer living with early-onset Alzheimer’s, participated in the clinical trials for the first-ever disease-modifying Alzheimer’s drug. Now, he…
A new disease-modifying Alzheimer’s drug, lecanemab — which will be distributed under the brand name Leqembi — today secured FDA approval. Today, the Food…
Will experimental drug lecanemab be safe and effective in treating Alzheimer’s? Being Patient shares what we know so far, and asks experts for direct…
Loss of appetite or stopping eating entirely is common among patients with late-stage Alzheimer’s. Why does it happen, and what can caregivers do? A…
Cuba has quietly been developing their own Alzheimer’s treatment. It’s administered nasally. And it’s just entered clinical trials. The United States imposed a blockade…